Dimensional Fund Advisors
SQZ

Dimensional Fund Advisors’s SQZ Biotechnologies Company SQZ Stock Holding History

Dimensional Fund Advisors’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$43K Buy
18,984
+2,966
+19% +$8.9K ﹤0.01% 3419
2022
Q2 		$51K Buy
+16,018
New +$57.6K ﹤0.01% 3385

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
AIG
American International Group New York $2.93M AUM 12.08% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors's SQZ Position: Q3 2022 in Review

Dimensional Fund Advisors increased its SQZ Biotechnologies Company (SQZ) stake by 19% in Q3 2022, buying an estimated $8.9K and bringing the position to 18,984 shares worth $43K. The position accounts for ﹤0.01% of the portfolio, ranked #3419.

Dimensional Fund Advisors first reported a position in SQZ in Q2 2022 and has held it in 2 quarters since. The position peaked at $51K in Q2 2022. 48 funds tracked by Wall St. Rank hold SQZ as of Q3 2022.

  • Dimensional Fund Advisors held 18,984 shares of SQZ Biotechnologies Company worth $43K as of Q3 2022.
  • Dimensional Fund Advisors bought 2,966 SQZ Biotechnologies Company shares in Q3 2022, an estimated $8.9K.
  • SQZ Biotechnologies Company made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #3419 holding.
  • Dimensional Fund Advisors first reported a position in SQZ Biotechnologies Company in Q2 2022 and has held it in 2 quarters since.
  • Dimensional Fund Advisors's SQZ Biotechnologies Company position peaked at $51K in Q2 2022.
  • 48 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.